These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7638358)

  • 1. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
    Simon K; Zalewska M; Gładysz A; Rotter K; Piszko P; Głowacki A
    Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma fibronectin in chronic liver diseases].
    Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
    Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic importance of fibronectin in chronic liver diseases].
    Golubović M; Majkić-Singh N; Marković S; Sumarac Z; Obradović I
    Med Pregl; 1999; 52(1-2):35-8. PubMed ID: 10352502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C.
    Hackl NJ; Bersch C; Feick P; Antoni C; Franke A; Singer MV; Nakchbandi IA
    Scand J Gastroenterol; 2010 Mar; 45(3):349-56. PubMed ID: 20017652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Met-enkephalin in the liver as a marker of hepatocellular damage in chronic viral hepatitis type B and C.
    Cieśla A; Mach T; Pierzchała-Koziec K; Skwara P; Szczepański W
    Adv Med Sci; 2006; 51():261-4. PubMed ID: 17357322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions].
    Gironi A; Niccolai J; Fabbri LP; Niccolai M; Chisci C
    Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of fibronectin in hepatologic diagnosis].
    Simon K
    Wiad Lek; 1994; 47(21-24):854-8. PubMed ID: 8999701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
    Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease.
    Loguercio C; De Girolamo V; Federico A; Feng SL; Crafa E; Cataldi V; Gialanella G; Moro R; Del Vecchio Blanco C
    Biol Trace Elem Res; 2001 Sep; 81(3):245-54. PubMed ID: 11575681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.
    Shimizu Y; Nakano I; Katano Y; Shimizu H; Fukuda Y
    Hepatogastroenterology; 2005; 52(66):1809-13. PubMed ID: 16334782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of plasma fibronectin in Crohn's disease.
    Verspaget HW; Biemond I; Allaart CF; van Weede H; Weterman IT; Gooszen HG; Peña AS; Lamers CB
    Hepatogastroenterology; 1991 Jun; 38(3):231-4. PubMed ID: 1937361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
    Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
    Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
    Huang W; Gong FY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.